Invited Speakers

AIRWAY VISTA 2020

Invited Speakers

Speakers

Samy Suissa
Department of Epidemiology, Biostatistics and Medicine, McGill University

Samy Suissa is Director of the Centre for Clinical Epidemiology, Jewish General Hospital, and a Distinguished James McGill Professor of Epidemiology and Biostatistics, and Medicine, at McGill University, Montreal.

Professor Suissa has conducted many studies on the real world effects of medications used for different chronic diseases, including for asthma, COPD and IPF, and authored over 500 peer-reviewed papers. He specializes in research methods and serves on the editorial boards of various scientific journals, including the European Respiratory Journal, Chest, Lancet Respiratory Medicine, and Journal of COPD.

He is a fellow of the Royal Society of Canada and of the Canadian Academy of Health Science, has received the Distinguished Investigator award from the Canadian Institute of Health Research and the FC Donders Professorship Award from Universiteit Utrecht, Netherlands.

Speakers

Monica Kraft
University of Arizona Health Sciences

Dr. Monica Kraft is an internationally renowned physician-scientist who specializes in clinical and translational asthma research who is the Chair of the Department of Medicine at the University of Arizona College of Medicine-Tucson, as well as a Professor of Medicine and a Robert and Irene Flinn Endowed Chair in Medicine.
In addition to patient care and teaching, Dr. Kraft has published extensively in the area of adult asthma. Specifically, her research interests include the mechanisms of innate immune dysfunction, inflammation and infection in asthma, as well as evaluation of personalized/precision approaches to asthma therapy through clinical trials.
Dr. Kraft’s work has appeared in such journals as The New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology, Journal of American Medical Association, The Lancet and The Journal of Immunology. Her H index is 69. Her work has been continuously funded by the National Institutes of Health and The American Lung Association for over 25 years and she is currently a member of the NHLBI Advisory Council. Dr. Kraft has also received the Presidential Early Career Award for Scientists and Engineers, awarded by President Clinton at the White House in 2000. Dr. Kraft served as President of the American Thoracic Society, a major medical society for pulmonary, critical care and sleep providers from 2012-2013.

Speakers

Eric Hoffman
Professor of Radiology, Medicine and Biomedical Engineering, University of Iowa

Speakers

Craig P. Hersh
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School

Craig P. Hersh, MD, MPH is an Associate Physician at Brigham and Women’s Hospital and an Associate Professor of Harvard Medical School. He trained in pulmonary and critical care medicine and genetic epidemiology. His research integrates the tools of genetics, genomics and epidemiology to improve precision in the diagnosis and treatment of COPD and COPD subtypes. He has been actively involved in the COPDGene Study and has been the Principal Investigator of gene expression and biomarker ancillary studies supported by the National Institutes of Health and others. He is the site co-PI for the COPDGene Clinical Center and the clinical lead for the programs in COPD and Alpha-1 Antitrypsin Deficiency at Brigham and Women’s Hospital.

Speakers

Ratko Djukanovic
The University of Southampton

Ratko Djukanovic (www.uhs.nhs.uk/prof_djukanovic) is Professor of Medicine at Southampton University and Consultant Respiratory Physician at the Southampton University Hospital NHS Trust. He is a NIHR Senior Investigator and a Fellow of the European Respiratory Society. As the Theme Lead for Respiratory and Critical Care in the NIHR Southampton Biomedical Research Centre, he heads a translational research programme across the life-course, including severe asthma, Chronic Obstructive Pulmonary Disease (COPD), rare lung diseases (CF, ILD, PCD), intensive care, lung cancer, respiratory infections and biomarkers for stratified medicine.

Professor Djukanovic has been a pioneer in stratifying asthma and has focused on projects in asthma that aim to develop and take advantage of a stratified medicine approach in this common condition. His special interest in the mechanisms of severe asthma and development of drugs and biomarkers for this condition. He is recognised for his collaborative approach to research involving academia and pharma. Professor Djukanovic co-founded UBIOPRED, the IMI-funded €22M programme in severe asthma which is applying the latest state of the art ‘omics technologies, to stratify asthma into phenotypes. He has been three times Chair of the Steering Group of the Translational Research Partnership, a consortium of UK centres of respiratory research excellence working with industry to help drug development. He is the founder and Chair of the European Severe Asthma Clinical Collaboration (SHARP). In his NHS clinic, Professor Djukanovic is particularly engaged in assessing the contribution of upper gastro-intestinal co-morbidity (reflux) to asthma severity and chronic cough, which he achieves within a multi-disciplinary team consisting of a gastroenterologist, an upper GI surgeon and an ENT Consultant.

Speakers

Nadia Hansel
Johns Hopkins School of Medicine

Speakers

Naoki Hasegawa
Department of Infectious Diseases, Keio University School of Medicine

Speakers

Hui Fang Lim
Respiratory and Critical Care Medicine, National University of Singapore

Speakers

Ching-Hsiung Lin
Changhua Christian Hospital

Ching-Hsiung Lin is Chief Medical Director of Changhua Christian Hospital, Director of Public Affair and Policy Society of Pulmonary and Critical Care Medicine, and Associate Professor at Institute of Genomics and Bioinformatics, National Chung Hsing University. Professor Lin received his medical degree from Kaohsiung Medical University and earned MS degree from Institute of Environmental Health, China Medical University in 2003. He subsequently completed his PhD at Graduate Institute of Medicine, Kaohsiung Medical University in 2011. Professor Lin’s main research main research interests include chronic obstructive pulmonary disease (COPD) and asthma, focused on the specific areas of COPD diagnosis, management, and prevention. Professor Lin has published 68 papers in peer reviewed journal, and he is also Taiwan COPD guideline committee member. From 2017 to present, Professor Lin devote to promoting Taiwan COPD control program including COPD pay-for-performance program and COPD early detection.

Speakers

Joon Beom Seo
Asan Medical Center

TBA

Speakers

Yeon-Mok Oh
Asan Medical Center

TBA

Speakers

Tae-Bum Kim
Asan Medical Center

TBA

Speakers

Woo Jin Kim
Kangwon National University Hospital

TBA

Speakers

Chin Kook Rhee
Seoul St. Mary’s Hospital

TBA

Speakers

Min-Suk Yang
Seoul National University Hospital

TBA

Speakers

Min-Hye Kim
Ewha Womans University School of Medicine and Medical Center

TBA

Speakers

Hyun Lee
Hanyang University Hospital

TBA

Speakers

Su Jeong Kim
Kyungpook National University Hospital

TBA

Speakers

Chan Sun Park
Haeundae Paik Hospital

TBA

Speakers

Hyun Hui Kang
Eunpyeong St.Mary’s Hospital

TBA

Speakers

Bo young Lee
Soonchunhyang university hospital

TBA

Speakers

Il-Young Jang
Asan Medical Center

TBA